News
There are only four FDA approved drugs to alleviate symptoms of #AlzheimersDisease but none that treat the disease. #CompChem is a valuable resource in helping to characterize and understand new protein targets. bit.ly/2KItgc0 #DrugDiscovery #MoleculeDesign #Alzheimers pic.twitter.com/nDjHtGi5ZR
I am delighted to announce that a new release of Cresset workflow components for the Pipeline Pilot™ environment is now available. These ...
Kinase inhibitors have established themselves as cancer therapeutics but does this family of enzymes have a role to play in ...
Cambridge, UK – 22 May 2019 – Cresset, innovative provider of outstanding software for molecule discovery, is pleased to announce the ...
A new release of workflow components for the KNIME™ environment is now available. This includes nodes for the Machine Learning ...
Run Cresset calculations in the Cloud with Cresset Engine Broker™ and ElastiCluster Paolo Tosco describes how to instantiate a cluster on ...
Flare™ V2 introduced a new analysis method called Electrostatic Complementarity™ (EC). The basic idea is quite simple: the maximum electrostatic affinity ...
Today, Medicines Discovery Catapult’s Virtual R&D Discovery Services platform have announced new partnerships to boost UK life sciences R&D and international ...
Cresset Discovery Services has extensive experience working on established and novel anti-microbial targets. We understand the unique challenges of antibiotic development ...
In this post I will describe how to instantiate a cluster on Google Cloud (or any other cloud platform supported by ElastiCluster) and ...
On 12th April 2019, the International Centre for Genetic Engineering and Biotechnology, New Delhi, India, hosted the symposium ‘Innovative Software for ...
Academia and industry always have a lot to gain from cultivating close ties with each other. As with any relationship, ...
Rapid interpretation of patent SAR using Forge™ Tim Cheeseright explains how Forge can be used to rapidly convert patent data into ...